Close

Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119

Go back to Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119

ICU Medical (ICUI) Tops Q2 EPS by 10c, Offers FY Guidance

August 8, 2016 4:13 PM EDT

ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $1.15, $0.10 better than the analyst estimate of $1.05. Revenue for the quarter came in at $96.7 million versus the consensus estimate of $89.66 million.

GUIDANCE:

ICU Medical sees FY2016 EPS of $4.45-$4.60, versus the consensus... More